Metastatic Prostate Cancer

conference reporter

by Christopher J. Logothetis, MD

An analysis shared at the 2022 Genitourinary Cancers Symposium highlights the importance of considering a patient's treatment preferences and quali......READ MORE

conference reporter

by Scott T. Tagawa, MD, MS, FACP

Data presented at the 2022 Genitourinary Cancers Symposium offer new insights into the utility of prostate-specific membrane antigen positron emiss......READ MORE

conference reporter

by Scott T. Tagawa, MD, MS, FACP

At the 2022 Genitourinary Cancers Symposium, several presentations highlighted the progress that has been made with targeted radioligand therapy fo......READ MORE

conference reporter

by Judd W. Moul, MD

Data reported at the 2022 Genitourinary Cancers Symposium highlight disparities in prostate cancer care.Following these proceedings, featured exper......READ MORE

conference reporter

by Judd W. Moul, MD

Data from the 2022 Genitourinary Cancers Symposium continue to shed light on the role of prostate cancer biomarkers in screening, staging, and trea......READ MORE